Back
Madrigal Pharmaceuticals Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
259.70
Seasonality Move:
31.67%
7 Day Trial
ALL ACCESS PASS
$
7
#1 ETF for Monthly Dividend
Click HERE to learn more.Madrigal Pharmaceuticals Price Quote
$259.70
+0.36 (+20.27%)
(Updated: November 1, 2024 at 6:32 AM ET)
Madrigal Pharmaceuticals Key Stats
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Day range:
$238.04 - $263.54
52-week range:
$133.99 - $299.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.57%
Volume:
1.3M
Avg. volume:
328.2K
1-year change:
97.4%
Market cap:
$5.6B
Revenue:
$0
EPS:
$-25.54
How Much Does Madrigal Pharmaceuticals Make?
Data Unavailable
Is Madrigal Pharmaceuticals Growing As A Company?
Data Unavailable
Madrigal Pharmaceuticals Stock Price Performance
-
Did Madrigal Pharmaceuticals Stock Go Up Last Month?
Madrigal Pharmaceuticals share price went up by 22.2% last month -
Did MDGL's Share Price Rise Over The Last Year?
MDGL share price rose by 97.4% over the past 1 year
What Is Madrigal Pharmaceuticals 52-Week High & Low?
-
What Is Madrigal Pharmaceuticals’s 52-Week High Share Price?
Madrigal Pharmaceuticals has traded as high as $299.98 over the past 52 weeks -
What Is Madrigal Pharmaceuticals’s 52-Week Low Share Price?
Madrigal Pharmaceuticals has traded as low as $133.99 over the past 52 weeks
Madrigal Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Madrigal Pharmaceuticals?
-
How Much Debt Does Madrigal Pharmaceuticals Have?
Total long term debt quarterly is $116.6M -
How Much Cash Does Madrigal Pharmaceuticals Have?
Cash and short term investments quarterly total is $1.1B -
What Is Madrigal Pharmaceuticals’s Book Value Per Share?
Book value per share is 39.50
Is Madrigal Pharmaceuticals Cash Flow Positive?
-
What Is MDGL Cash Flow From Operations?
Cash flow from operations (TTM) is -$449M -
What Is Madrigal Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Madrigal Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$336M
Madrigal Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MDGL return on invested capital is -91.11% -
What Is Madrigal Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -75.89% -
What Is MDGL Return On Equity?
ROE is a measure of profitability and is -113.99%
Madrigal Pharmaceuticals Earnings Date & Stock Price
-
What Is Madrigal Pharmaceuticals's Stock Price Today?
A single share of MDGL can be purchased today for 259.34 -
What Is Madrigal Pharmaceuticals’s Stock Symbol?
Madrigal Pharmaceuticals trades on the nasdaq under the ticker symbol: MDGL -
When Is Madrigal Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Madrigal Pharmaceuticals is scheduled on February 28, 2025 -
When Is MDGL's next ex-dividend date?
Madrigal Pharmaceuticals's next ex-dividend date is November 1, 2024 -
How To Buy Madrigal Pharmaceuticals Stock?
You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Madrigal Pharmaceuticals Competitors
-
Who Are Madrigal Pharmaceuticals's Competitors?
Below is a list of companies who compete with Madrigal Pharmaceuticals or are related in some way:
Madrigal Pharmaceuticals Dividend Yield
-
What Is MDGL Dividend Yield?
Madrigal Pharmaceuticals’s dividend yield currently is 0% -
What Is Madrigal Pharmaceuticals’s Payout Ratio?
Madrigal Pharmaceuticals’s payout ratio is 0% -
When Did Madrigal Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Madrigal Pharmaceuticals’s Dividend Per Share?
Madrigal Pharmaceuticals pays a dividend of $0.00 per share
Madrigal Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 28.8% |
| Revenue: | 0% | 80.67% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 362.79 |
| Upside from Last Price: | 39.89% |